Published in Eur J Pharmacol on April 18, 1997
Functional GI disorders: from animal models to drug development. Gut (2007) 1.55
Stress and visceral pain: from animal models to clinical therapies. Exp Neurol (2011) 1.25
Peripheral kappa-opioid agonists for visceral pain. Br J Pharmacol (2004) 1.22
Activation of peripheral kappa opioid receptors inhibits capsaicin-induced thermal nociception in rhesus monkeys. J Pharmacol Exp Ther (1999) 0.94
Centrally acting agents and visceral sensitivity. Gut (2002) 0.85
The role of experimental models in developing new treatments for irritable bowel syndrome. Expert Rev Gastroenterol Hepatol (2011) 0.83
Asimadoline, a kappa-opioid agonist, and satiation in functional dyspepsia. Aliment Pharmacol Ther (2008) 0.83
Pharmacotherapy: non-serotonergic mechanisms. Gut (2002) 0.76
A proposal for the classification of sigma binding sites. Trends Pharmacol Sci (1992) 2.65
N-methyl-D-aspartate-induced neuronal activation is selectively modulated by sigma receptors. Eur J Pharmacol (1990) 1.17
A database of mutants and effects of site-directed mutagenesis experiments on G protein-coupled receptors. Proteins (1996) 1.17
Chlorpromazine, methotrimeprazine, and metabolites. Structural changes accompanying the loss of neuroleptic potency by ring sulfoxidation. Mol Pharmacol (1982) 1.16
GnRH antagonists: a new generation of long acting analogues incorporating p-ureido-phenylalanines at positions 5 and 6. J Med Chem (2001) 1.06
Conditioned emotional response in rats enhances colonic motility through the central release of corticotropin-releasing factor. Gastroenterology (1991) 1.03
The presence of lipocortin in human embryonic skin fibroblasts and its regulation by anti-inflammatory steroids. Biochim Biophys Acta (1985) 1.01
Traditional tea drinking in Senegal. A real source of fluoride intake for the population. Odontostomatol Trop (1999) 0.97
Plasma level monitoring of antipsychotic drugs. Clinical utility. Clin Pharmacokinet (1986) 0.96
Pharmacokinetics of chlorpromazine after single and chronic dosage. Clin Pharmacol Ther (1977) 0.96
Clinical and experimental progression of a new model of human prostate cancer and therapeutic approach. Am J Pathol (2001) 0.95
Peripheral kappa-opioid receptors mediate the antinociceptive effect of fedotozine (correction of fetodozine) on the duodenal pain reflex inrat. Eur J Pharmacol (1994) 0.95
Involvement of prostaglandins and CGRP-dependent sensory afferents in peritoneal irritation-induced visceral pain. Regul Pept (1997) 0.95
Distinct neuroprotective profiles for sigma ligands against N-methyl-D-aspartate (NMDA), and hypoxia-mediated neurotoxicity in neuronal culture toxicity studies. Brain Res (1995) 0.95
Opioid regulation of mucosal ion transport in the mouse isolated jejunum. J Pharmacol Exp Ther (1990) 0.93
In vitro stimulation of the prepubertal rat gonadotropin-releasing hormone pulse generator by leptin and neuropeptide Y through distinct mechanisms. Endocrinology (2000) 0.93
Pregabalin decreases visceral pain and prevents spinal neuronal activation in rats. Gut (2007) 0.92
Pharmacokinetics of butixocort 21-propionate, budesonide, and beclomethasone dipropionate in the rat after intratracheal, intravenous, and oral treatments. Drug Metab Dispos (1991) 0.92
Vagally mediated inhibition of acoustic stress-induced cortisol release by orally administered kappa-opioid substances in dogs. Endocrinology (1989) 0.92
Fedotozine reverses ileus induced by surgery or peritonitis: action at peripheral kappa-opioid receptors. Gastroenterology (1993) 0.91
JO 1784, a potent and selective ligand for rat and mouse brain sigma-sites. J Pharm Pharmacol (1990) 0.90
Central nervous system pharmacology of neuropeptide Y. Pharmacol Ther (1995) 0.90
Purification and biochemical characterization of dog gastric lipase. Eur J Biochem (1991) 0.89
Dehydroepiandrosterone sulfate attenuates dizocilpine-induced learning impairment in mice via sigma 1-receptors. Behav Brain Res (1997) 0.89
Interleukin 1 induces a neurally mediated colonic secretion in rats: involvement of mast cells and prostaglandins. Gastroenterology (1994) 0.89
Maintenance therapy with a new retard tablet preparation of procainamide. Am Heart J (1976) 0.88
Effect of fedotozine on the cardiovascular pain reflex induced by distension of the irritated colon in the anesthetized rat. Eur J Pharmacol (1994) 0.88
A C-fiber reflex modulated by heterotopic noxious somatic stimuli in the rat. J Neurophysiol (1994) 0.88
Analgesic and antiinflammatory effects of two novel kappa-opioid peptides. Anesthesiology (2001) 0.88
Phenothiazine drugs and metabolites: molecular conformation and dopaminergic, alpha adrenergic and muscarinic cholinergic receptor binding. Biochem Pharmacol (1986) 0.87
Opposite effects of kappa-opioid agonists on gastric emptying of liquids and solids in dogs. Gastroenterology (1988) 0.87
Response heterogeneity of 5-HT3 receptor antagonists in a rat visceral hypersensitivity model. Eur J Pharmacol (1996) 0.86
Effects of fedotozine on gastrointestinal motility in dogs: mechanism of action and related pharmacokinetics. J Pharm Pharmacol (1990) 0.86
Fedotozine, a kappa-opioid agonist, prevents spinal and supra-spinal Fos expression induced by a noxious visceral stimulus in the rat. Neurogastroenterol Motil (2000) 0.86
Inhibitors of free radical formation fail to attenuate direct beta-amyloid25-35 peptide-mediated neurotoxicity in rat hippocampal cultures. J Neurosci Res (1994) 0.86
Neuropeptide Y and sigma ligand (JO 1784) suppress stress-induced colonic motor disturbances in rats through sigma and cholecystokinin receptors. J Pharmacol Exp Ther (1992) 0.86
Specific binding of [3H]rauwolscine to alpha 2-adrenoceptors in rat cerebral cortex: comparison between crude and synaptosomal plasma membranes. J Neurochem (1983) 0.86
Pharmacokinetics of methotrimeprazine after single and multiple doses. Clin Pharmacol Ther (1976) 0.86
Reversal by kappa-agonists of peritoneal irritation-induced ileus and visceral pain in rats. Life Sci (1997) 0.85
Evidence for a non-opioid sigma binding site in the guinea-pig myenteric plexus. Life Sci (1988) 0.85
Screening of preduodenal lipases in several mammals. Biochim Biophys Acta (1988) 0.85
In vivo modulation of sigma receptor sites by calcitonin gene-related peptide in the mouse and rat hippocampal formation: radioligand binding and electrophysiological studies. Eur J Neurosci (1995) 0.85
Effects of neuropeptide Y, peptide YY and sigma ligands on ion transport in mouse jejunum. J Pharmacol Exp Ther (1993) 0.85
Effects of isozyme-selective phosphodiesterase inhibitors on eosinophil infiltration in the guinea-pig lung. Eur J Pharmacol (1994) 0.84
Evidence for an anti-amnesic effect of JO 1784 in the rat: a potent and selective ligand for the sigma receptor. Brain Res (1991) 0.84
Molecular modeling of serotonin, ketanserin, ritanserin and their 5-HT2C receptor interactions. Eur J Pharmacol (1996) 0.83
Molecular dynamics of the 5-HT1a receptor and ligands. Protein Eng (1993) 0.83
Tonic regulation of mouse ileal ion transport by nitric oxide. J Pharmacol Exp Ther (1994) 0.83
Phenothiazine drug metabolites: dopamine D2 receptor, alpha 1- and alpha 2-adrenoceptor binding. Eur J Pharmacol (1986) 0.83
A novel receptor for calcitonin gene-related peptide (CGRP) mediates secretion in the rat colon: implications for secretory function in colitis. FASEB J (2000) 0.82
CCK antagonists: pharmacology and therapeutic interest. Pharmacol Ther (1994) 0.82
Anti-inflammatory effect of LA 2851 and reference drugs on some models of inflammation. Investigation of the mechanism of action. Agents Actions (1982) 0.82
Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype. Endocrinology (1999) 0.82
[Initial results with caerulein in pancreatic function tests in man]. Acta Gastroenterol Belg (1971) 0.82
Total pancreatic insufficiency in pigs: a model to study intestinal enzymes and plasma levels of digestive hormones after pancreatic supplementation by a whole pancreas preparation. Pancreas (1989) 0.82
Antinociceptive effects of neuropeptide Y and related peptides in mice. Brain Res (1996) 0.81
Central neuropeptide Y and the sigma ligand, JO 1784, reverse corticotropin-releasing factor-induced inhibition of gastric acid secretion in rats. Br J Pharmacol (1992) 0.81
Neuropeptide Y and peptide YY interact with rat brain sigma and PCP binding sites. Eur J Pharmacol (1989) 0.81
Antinociceptive effects of morphine and U-50,488H on vaginal distension in the anesthetized rat. Life Sci (1997) 0.81
Neuropeptide Y and JO 1784, a selective sigma ligand, alter intestinal ion transport through a common, haloperidol-sensitive site. Eur J Pharmacol (1990) 0.81
Autoradiographic localization of sigma opioid receptors in the gastrointestinal tract of the guinea pig. Gastroenterology (1989) 0.81
Anaphylactic colonic hypersecretion in cow's milk sensitized guinea-pigs depends upon release of interleukin-1, prostaglandins and mast cell degranulation. Aliment Pharmacol Ther (1994) 0.81
Continuous electrical and mechanical activity recording in the gut of the conscious rat. J Pharmacol Methods (1981) 0.80
Molecular structure and dynamics of cis(Z)-and trans(E)-flupenthixol and clopenthixol. Pharm Res (1991) 0.80
Ligand induced conformational states of the 5-HT(1A) receptor. Eur J Pharmacol (2001) 0.80
Role of vagal afferents in the antinociception produced by morphine and U-50,488H in the colonic pain reflex in rats. Eur J Pharmacol (1994) 0.80
Purification, characterization and kinetic properties of the rabbit gastric lipase. Biochim Biophys Acta (1988) 0.80
[The ameloblastomas in Africa]. Rev Stomatol Chir Maxillofac (1968) 0.80